Enhanced oxygen radical production in a transgenic mouse model of familial amyotrophic lateral sclerosis

Annals of Neurology

Volumn 44, Issue 5, 1998, Pages 763-770

  Liu, Rugao ^a,d   Althaus, John S ^b   Ellerbrock, Brenda R ^b   Becker, David A ^c   Gurney, Mark E ^a,b,d  

^a WESTERN MICHIGAN UNIVERSITY   (United States)

^b PFIZER INC   (United States)

^c FLORIDA INTERNATIONAL UNIVERSITY   (United States)

^d PARKER HUGHES INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COPPER ZINC SUPEROXIDE DISMUTASE; FREE RADICAL; OXYGEN RADICAL;

AMYOTROPHIC LATERAL SCLEROSIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL SURVIVAL; CONTROLLED STUDY; ENZYME ACTIVITY; FAMILIAL DISEASE; GENE EXPRESSION REGULATION; GENE MUTATION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; MOUSE; NERVE DEGENERATION; NONHUMAN; PRIORITY JOURNAL; SPINAL CORD MOTONEURON; TRANSGENIC MOUSE;

EID: 0031768025     PISSN: 03645134     EISSN: None     Source Type: Journal    
DOI: 10.1002/ana.410440510     Document Type: Article

References (33)

1. Williams DB, Windebank AJ. Motor neuron disease (amyotrophic lateral sclerosis). Mayo Clin Proc 1991;66:54-82
2. Rosen DR, Siddique T, Patterson D, et al. Mutations in CuZn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis. Nature 1993;362:59-62
3. Deng H-X, Hentati A, Tainer JA, et al. Amyotrophic lateral sclerosis and structural defects in CuZn superoxide dismutase. Science 1993;362:1047-1051
4. Borchelt DR, Lee MK, Slunt HS, et al. Superoxide dismutase 1 with mutations linked to familial amyotrophic lateral sclerosis possesses significant activity. Proc Natl Acad Sci USA 1994;91: 8292-8296
5. 90Ala mutation in CuZn-superoxide dismutase. Nat Genet 1995;10: 61-66
6. Gurney ME, Pu H, Chiu AY, et al. Motor neuron degeneration in mice that express a human CuZn superoxide dismutase mutation. Science 1994;264:1772-1775
7. Wong PC, Pardo CA, Borchelt DR, et al. An adverse property of a familial ALS linked SOD1 mutation causes motor neuron disease characterized by vacuolar degeneration og mitochondria. Neuron 1995;14:1105-1116
8. Dal Canto MC, Gurney ME. A low expressor line of transgenic mice carrying a mutant human CuZn superoxide dismutase (SOD1) gene develops pathological changes which most closely resemble those in human ALS. Acta Neuropathol 1997;93:537-550
9. Gurney ME. Transgenic animal models of familial amyotrophic lateral sclerosis. J Neurol 1997;244(Suppl 2):S15-S20
10. Wiedau Pazos M, Goto JJ, Rabizadeh S, et al. Altered reactivity of superoxide dismutase in familial amyotrophic lateral sclerosis. Science 1996;271:515-518
11. m for hydrogen peroxide. Proc Natl Acad Sci USA 1996;93:5709-5714
12. Hodgson EK, Fridovich I. The interaction of bovine erythrocyte superoxide dismutase with hydrogen peroxide: inactivation of the enzyme. Biochemistry 1975;14:5294-5299
13. Yim MB, Chock PB, Stadtman ER. Copper zinc superoxide dismutase catalyzes hydroxyl radical production from hydrogen peroxide. Proc Natl Acad Sci USA 1990;87:5006-5010
14. Yim MB, Chock PB, Stadtman ER. Enzyme function of copper zinc superoxide dismutase as a free radical generator. J Biol Chem 1993;268:4099-4105
15. Lyons TJ, Liu H, Goto JJ, et al. Mutations in copper-zinc superoxide dismutase that cause amyotrophic lateral sclerosis alter the zinc binding site and the redox behavior of the protein. Proc Natl Acad Sci USA 1996;93:12240-12244
16. Becker DA. Highly sensitive colorimetric detection and facile isolation of diamagnetic free radical adducts of novel chromotropic nitrone spin trapping agents readily derived from guaiazulene. J Am Chem Soc 1996;118:905-906
17. Althaus JS, Fleck TJ, Becker DA, et al. Azulenyl nitrones: colorimetric detection of oxyradical end products and neuroprotection in the gerbil forebrain ischemia/reperfusion model. Free Radic Biol Med 1998;24:738-744
18. Chiu AY, Zhai P, Dal Canto MC, et al. Age dependent penetrance of disease in a transgenic mouse model of familial amyotrophic lateral sclerosis. Mol Cell Neurosci 1995;6:349-362
19. Beauchamp C, Fridovich I. Superoxide dismutase: improved assays and an assay applicable to acrylamide gels. Anal Biochem 1971;44:276-287
20. Althaus JS, Andrus PK, Hall ED, et al. Improvements in the salicylate trapping method for measurement of hydroxyl radical levels in the brain. In: Ohnishi ST, Ohnishi T, ed. Central nervous system trauma: research techniques. Boca Raton, FL: CRC Press, 1995:437-444
21. Tsuda T, Munthasser S, Fraser PE, et al. Analysis of the functional effects of a mutation in SOD1 associated with familial amyotrophic lateral sclerosis. Neuron 1994;13:727-736
22. Brujin LI, Becher MW, Lee MK, et al. ALS-linked SOD1 mutant G85R mediates damage to astrocytes and promotes rapidly progressive disease with SOD1-containing inclusions. Neuron 1997;18:327-338
23. Kellogg EW, Fridovich I. Superoxide dismutase in the rat and mouse as a function of age and longevity. J Gerontol 1976;31: 405-408
24. De Haan JB, Newman JD, Kola I. Cu/Zn superoxide dismutase mRNA and enzyme activity, and susceptibility to lipid peroxidation, increases with aging in murine brains. Mol Brain Res 1992;13:179-187
25. Dal Canto MC, Gurney ME. The development of CNS pathology in a murine transgenic model of human ALS. Am J Pathol 1994;145:1271-1279
26. Dal Canto MC, Gurney ME. Neuropathological changes in two lines of mice carrying a transgene for mutant human CuZn SOD and in mice overexpressing wild type human SOD: a model of familial amyotrophic lateral sclerosis (FALS). Brain Res 1995;676:25-40
27. Kostic V, Gurney ME, Deng H-X, et al. Midbrain dopaminergic neuronal degeneration in a transgenic model of familial amyotrophic lateral sclerosis. Ann Neurol 1997;41:497-504
28. Hottinger AF, Fine EG, Gurney ME, et al. The copper chelator d-penicillamine delays onset of disease and extends survival in a transgenic mouse model of familial amyotrophic lateral sclerosis. Eur J Neurosci 1997;9:1548-1551
29. Gurney ME, Cutting FB, Zhai P, et al. Benefit of vitamin E riluzole and gabapentin in a transgenic model of familial amyotrophic lateral sclerosis. Ann Neurol 1996;39:147-157
30. Dugan LL, Turetsky DM, Du C, et al. Carboxyfullerenes as neuroprotective reagents. Proc Natl Acad Sci USA 1997;94: 9434-9439
31. Kostic V, Jackson-Lewis V, de Bilbao F, et al. Bcl-2: prolonging life in a transgenic model of familial amyotrophic lateral sclerosis. Science 1997;277:559-562
32. Kane DJ, Sarafian TA, Anton R, et al. Bcl-2 inhibition of neural death: decreased generation of reactive oxygen species. Science 1993;262:1274-1277
33. Hockenbery DM, Oltvai ZN, Yin XM, et al. Bcl-2 functions in an antioxidant pathway to prevent apoptosis. Cell 1993;75: 241-251